This inventor holds 1 USPTO granted patent. Top assignee: Hk Inno.n Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jae Hee Cheon: Innovator in Pharmaceutical Composition
Introduction
Jae Hee Cheon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating gastrointestinal disorders. His innovative work has garnered attention in the scientific community.
Latest Patents
Jae Hee Cheon holds a patent for a pharmaceutical composition comprising a benzimidazole derivative compound. The invention focuses on a composition for preventing or treating colitis, utilizing tegoprazan as an effective ingredient. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Cheon is associated with Hk Inno.n Corporation, where he continues to work on groundbreaking pharmaceutical innovations. His role in the company allows him to collaborate with other talented professionals in the field, contributing to the development of new therapeutic solutions.
Collaborations
Some of Jae Hee Cheon's notable coworkers include Dongkyu Kim and Bong Tae Kim. Their collaborative efforts enhance the research and development capabilities within their organization, fostering an environment of innovation.
Conclusion
Jae Hee Cheon exemplifies the spirit of innovation in the pharmaceutical industry. His work on benzimidazole derivative compounds demonstrates his dedication to improving healthcare solutions. Through his contributions, he continues to make a positive impact on the field of medicine.